Infectious vaginopathies in pregnancy.
D000935:Antifungal Agents / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006069:Gonorrhea / Q000175:diagnosis / Q000188:drug therapy; D006192:Haemophilus Infections / Q000175:diagnosis / Q000188:drug therapy; D006561:Herpes Simplex / Q000175:diagnosis; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D008795:Metronidazole / Q000627:therapeutic use; D009175:Mycoplasma Infections / Q000175:diagnosis; D009878:Ophthalmia Neonatorum / Q000517:prevention & control; D010402:Penicillin G Procaine / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011254:Pregnancy in Diabetics / Q000150:complications; D013587:Syphilis / Q000188:drug therapy; D013588:Syphilis Serodiagnosis; D013590:Syphilis, Congenital / Q000517:prevention & control; D013752:Tetracycline / Q000627:therapeutic use; D014247:Trichomonas Vaginitis / Q000175:diagnosis / Q000188:drug therapy; D014623:Vaginal Diseases / Q000188:drug therapy
D000935:Antifungal Agents; D005938:Glucocorticoids; D008795:Metronidazole; D010402:Penicillin G Procaine; D013752:Tetracycline